These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7379980)

  • 21. Biosynthesis of cytidine nucleotides in rat liver after administration of D-galactosamine.
    Seifert J; Buchar E
    Chem Biol Interact; 1981 May; 35(2):217-28. PubMed ID: 6163566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis.
    Decker K; Keppler D; Rudigier J; Domschke W
    Hoppe Seylers Z Physiol Chem; 1971 Mar; 352(3):412-8. PubMed ID: 5108038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiac uracil nucleotides and glycogen: effect of uridine and ribose administration in the rat].
    Aussedat J; Verdetti J; Grably S; Rossi A
    J Physiol (Paris); 1982; 78(3):331-6. PubMed ID: 6820048
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased conversion of uridine-5'-phosphate and uridine-5'-triphosphate to cytosine nucleotides by a liver fraction from colchicine-treated rats.
    Weinfeld H; Sandberg AA
    Biochem Pharmacol; 1967 Feb; 16(2):375-83. PubMed ID: 6029918
    [No Abstract]   [Full Text] [Related]  

  • 25. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin.
    Mihas AA; Ceballos R; Mihas TA; Hirschowitz BI
    J Med; 1990; 21(6):301-11. PubMed ID: 2093097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between uracil nucleotide concentrations and glycogen synthesis in hepatocytes from fed and fasted rats.
    Songu E; Haugaard ES; Wildey G; Haugaard N
    Metabolism; 1981 Feb; 30(2):119-22. PubMed ID: 7464560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: lack of involvement in cytotoxicity.
    McMillan JM
    J Biochem Mol Toxicol; 1999; 13(3-4):135-42. PubMed ID: 10098898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of uridine supply on glycogen resynthesis after ischaemia in the isolated perfused rat heart.
    Aussedat J
    Cardiovasc Res; 1983 Mar; 17(3):145-51. PubMed ID: 6871904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural study of liver cell injury due to UTP deficiency.
    Shinozuka H
    Virchows Arch B Cell Pathol; 1974 Mar; 15(2):119-30. PubMed ID: 4212499
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose 1,6-bisphosphate.
    De Oliveira JR; Rosa JL; Ambrosio S; Bartrons R
    Hepatology; 1992 Jun; 15(6):1147-53. PubMed ID: 1317340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensification of galactosamine hepatotoxicity by polyriboinosinic acid-polyribocytidylic acid.
    Sakakibara S; Namba N; Shiomi K; Kagamiyama H
    Life Sci; 1985 Feb; 36(8):705-12. PubMed ID: 3974407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 33. Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping.
    Keppler DO
    Cancer Res; 1977 Mar; 37(3):911-7. PubMed ID: 189918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the age-dependent effects of galactosamine in primary rat hepatocyte cultures.
    Abdul-Hussain SK; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):504-13. PubMed ID: 2000637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene-mediated liver injury.
    Tiegs G; Wendel A
    Biochem Pharmacol; 1988 Jul; 37(13):2569-73. PubMed ID: 2839197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous ET-1 contributes to liver injury induced by galactosamine and endotoxin in isolated perfused rat liver.
    Ohuchi T; Tada K; Akamatsu K
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G997-1003. PubMed ID: 7611421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protecting action of aspartate on the hepatic changes induced by D-galactosamine.
    Fodor O; Schvartz M; Suciu A; Barbarino F; Duca S; Lezeu R
    Arzneimittelforschung; 1976; 26(5):855-8. PubMed ID: 183787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of glycogenolysis in perfused rat livers by glucagon and metabolic inhibitors.
    Jakob A; Diem S
    Biochim Biophys Acta; 1974 Oct; 362(3):469-79. PubMed ID: 4369746
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of D-galactosamine for a pulse-chase study of ribosomal RNA maturation in rat liver.
    Gajdardjieva KC; Dabeva MD; Chelibonova-Lorer H; Hadjiolov AA
    FEBS Lett; 1977 Dec; 84(1):48-52. PubMed ID: 590526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.